Ensoma and Interius BioTherapeutics: in vivo veritas
August 26, 2022
An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers
Media Coverage
Interius’ Senior Director of Analytical Development to Speak at 14th Annual Bioprocessing Summit
August 17, 2022
An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers
BioCentury’s 2021 Class of Emerging Companies
February 14, 2022
An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers
Interius Named as Finalist for the Deal of the Year Award by Life Sciences Pennsylvania
December 09, 2021
An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers
Penn Cell and Gene Therapy Spinout Interius Biotherapeutics Raises $76 Million
May 18, 2021